Datavant Inc. and Ciox Health believe their merger will create a health data network that will improve patient outcomes and reduce costs, overcoming data fragmentation by building a unified ecosystem.
Singapore-based Temasek will supply $200 million to G2 Management Co. Inc. to foster the development of therapies from the University of Pennsylvania's Gene Therapy Program, led by James Wilson.